Get Permission Raut, Shendre, and Khadse: A five-year study of Influenza A (H1N1) pandemic 09 from Central India


Introduction

Respiratory infections due to influenza virus are a major cause of morbidity and mortality all over the world. The first case of influenza A H1N1 was reported from Mexico in April, 2009. 1 Subsequently, the infection spread to across 74 countries with 30, 000 confirmed cases on June 11, 2009. This prompted the World Health Organization to raise the warning from phase 5 to phase 6.2 This was a new strain of the virus which was never seen before. Total 214 countries were affected by the pandemic worldwide. In India, the first case of influenza A H1N1 was reported on May 16, 2009 from Hyderabad.3 The World Health Organization declared the post pandemic phase on August 10, 2010.4 Subsequently, the influenza activity in the six regions of the world is on decline.5 This pandemic A(H1N1)2009 virus has been widely circulating across the globe since 2009, and is now established in human populations as a seasonal influenza virus. Currently there is no longer a pandemic virus circulating in the world. Yet, in India, the past decade saw as many as 1.58 lakh persons being infected by the virus and over 10,000 succumbing to it. IDSP data show that the epidemiology of influenza A (H1N1) is changing in terms of geographical distribution, age and seasonality.6 In view of lack of epidemiological information on trends of pandemic influenza A H1N1 from India, the present study was conducted at Viral Research and Diagnostic Lab (VRDL), Indira Gandhi Govt. Medical College (IGGMC), Nagpur which is one among five identified Govt. labs involved for testing of Influenza A (H1N1)pandemic 09 in Maharashtra State and one and only lab in Vidarbha region of Maharashtra.

Materials and Methods

Clinically, suspected cases belonging to Category C as per the guidelines on the categorisation of H1N1 cases7 only were included in the study. Throat/nasal /nasopharyngeal swabs/aspirates were collected by the treating physician in the viral transport medium and transported to Viral Research and Diagnostic Lab (VRDL), Indira Gandhi Govt. Medical College (IGGMC), Nagpur at 4°C. Till further processing, samples were stored at 4°C. Samples were received from all govt. institutions/ medical colleges from Vidarbha region of Maharashtra. Patients were divided into five age groups for the analysis of the results. Age Group I, Group II, Group III , Group IV and Group IV comprising 0-10, 11–20, 21–40, 41-60 and 61 years and above, respectively. Samples received from Oct-2015 (lab started functioning in oct-15) to Sep-2019 were included in the study. Different clinical and epidemiological parameters were noted in all positive cases.

The study was approved by Institute’s

Ethical committee

Samples were processed as under –

a) Ribonucleic acid (RNA) extraction – Coloumn based extraction was performed by QIAmp® viral RNA Mini Kit from Qiagen, USA.

b) Mastermix preparation – Mastermix was prepared by using following components and concentration and Extracted RNAs added last into the mix–

Table 1
S. No. Component Volume per reaction
1 Nuclease free water 6 µl
2 2X SuperScript III Master mix 12.5 µl
3 Primer probe mix 0.5 µl
4 Taqman Polymerase Enzyme 1 µl
5 Extracted RNA 5 µl
Total Volume 25 µl

c) Positive and Negative template control (PTC & NTC) were provided by National Institute of Virology (NIV), Pune.

Primer probe sequence’s that were used in the study were as follows –

Table 2
Primers and probes Sequence (5’ > 3’)
Inf A Forward GAC CRA TCC TGT CAC CTC TGA C
Inf A Reverse AGG GCA TTY TGG ACA AAK CGT CTA
Inf A Probe FAM – TGC AGT CCT CGC TCA CTG GGC ACG
Pdm H1 Forward GTG CTA TAA ACA CCA GCC TCC CAT T
Pdm H1 Reverse AGA YGG GAC ATT CCT CAA TCC TG
Pdm H1 Probe FAM – ATA CAT CCR ATC ACA ATT GGR AAA TGT CCA AA
Rnase P Forward AGA TTT GGA CCT GCG AGC G
Rnase P Reverse GAG CGG CTG TCT CCA CAA GT
Rnase P Probe FAM – TTC TGA CCT GAA GGC TCT GCG CG

d) RT-PCR : Samples were tested by reverse transcriptase realtime PCR (RT-PCR) for influenza type A using Step one and Step one plus Applied Biosystems Real time PCR machine by Thermofischer Scientific using cycling conditions of 50°C for 30 min of reverse transcription followed by Taq inhibitor inactivation at 95°C for 10 min and PCR amplification (45 cycles) at 95°C for 15 seconds and at 55°C for 30 seconds.

e) Results were interpreted depending upon the Cycle Threshold (CT) values. Curve for the given target was considered as positive if it crossed the threshold on or before 35 cycles. All samples indicated a positive curve for RNase P (crossed the threshold on or before 35 cycles, indicating the presence of sufficient human RNase P gene). Positivity for RNase P gene is a marker to assess the quality of the specimen.

f) Interpretation –

Figure 1
https://s3-us-west-2.amazonaws.com/typeset-media-server/6be6b598-ce49-493c-bcca-1b6f3c861700image1.png

During the study period, a total of 3690 samples were received for testing. Of these 3690 samples, 553 (15%) samples tested positive for influenza A H1N1 pandemic 09. Year wise distribution of cases is shown in Figure 2 . From 2015 – 2019, no. of females patients suspected to be having Influenza A (H1N1)pandemic 09 infection were more than male patient but positivity was almost equal throughout these years except in 2019 (M/F positivity was 7/12 %) as shown in Table 3. In 2015, maximum affectivity was seen in age groups 21-40 and 41- 60 years, which changed to 0-10 years in 2017 followed by again 21-40 years in 2018 and 11-20 years in 2019 as shown in Table 4. Looking at the districts most affected, in 2015 , Bhandara , Gondia and Wardha were most affected. In 2017, again Bhandara district was hit the most by the virus followed by Chandrapur district. In 2018, again Gondia had highest positivity and in the current year, Akola is the worstly affected district which was never in top three hit list districts from 2015 to 2017. From 2018, Akola came into top three districts with highest H1N1 positivity. Table 5 shows districtwise distribution of cases. Influenza A (H1N1) pandemic 09 is known to circulate in between Aug-Nov months. In last five years, we have seen peaks of infection in this same time period but peaks have also been noted in summer months (Figure 3). Clinical features associated with the infection are mentioned in Table 6.

Table 3

Year and gender-wise distribution of sample

Year Total tested No. of Positive Positivity in males Positivity in females
2015 387 74 (19%) 35/179 (19%) 39/208 (19%)
2016 310 1 (0.3%) 1/310 (0.3%) 0
2017 1765 377 (21%) 177/774 (23%) 200/991 (20%)
2018 922 70 (8%) 27/368 (7%) 43/554 (7%)
2019 (till date) 473 47 (10%) 12/173 (7%) 35/300 (12%)
Table 4

Age-wise distribution and positivity ofsamples n = no. of cases tested in that age group

Age group 2015 2016 2017 2018 2019
n Positive n Positive n Positive n Positive n Positive
0-10 yrs 103 16 (15%) 51 1 (2%) 283 68 (24%) 119 6 (5%) 29 1 (3%)
11- 20 yrs 36 3 (8%) 31 0 140 31 (22%) 119 9 (7%) 41 11 (26%)
21-40 yrs 129 31 (24%) 129 0 688 153 (22%) 329 30 (9%) 153 17 (11%)
41-60 yrs 78 20 (25%) 72 0 418 87 (21%) 227 19 (8%) 117 8 (7%)
61 and above 33 4 (12%) 20 0 191 31 (16%) 116 5 (4%) 60 6 (10%)
Table 5

District wise distribution of cases n = no. of cases tested from that district

Year 2015 2016 2017 2018 2019
District n Positive n Positive n Positive n Positive n Positive
Nagpur 292 47 (16%) 243 1 (0.4%) 986 188 (19%) 555 31 (5%) 308 27(9%)
Amravati 16 4 (25%) 0 0 359 86 (24%) 126 11 (8%) 26 2(8%)
Bhandara 14 5 (35%) 1 0 37 14 (38%) 1 0 3 0
Gondia 22 7 (31%) 25 0 9 1 (11%) 5 2 (40%) 0 0
Wardha 23 8 (34%) 4 0 113 26 (23%) 35 1 (3%) 11 1(9%)
Yavatmal 18 3 (16%) 19 0 51 12 (23%) 44 5 (11%) 4 0
Washim 2 0 0 0 3 0 1 0 0 0
Akola 0 0 18 0 147 31 (21%) 137 20 (14%) 106 18 (17%)
Chandrapur 0 0 0 0 54 19 (35%) 9 0 15 0
Gadchiroli 0 0 0 0 4 0 9 0 0 0
Table 6

Clinical features of positive cases

Symptoms 2015 2016 2017 2018 2019
n=74 (n%) n=1 (n%) n=377 (n%) n=70 (n%) n=31 (n%)
Fever 74 (100) 1 (100) 377 (100) 70 (100) 31 (100)
Breathlessness 53 (72) 1 (100) 313 (83) 53 (76) 21 (69)
Cough 61 (83) 1 (100) 264 (70) 56 (81) 23 (76)
Sore throat 19 (26) 79 (21) 13(18) 5 (16)
Myalgia 46 (62) 109 (29) 48 (69) 18 (58)
Arthralgia 15 (21) 72 (19) 13 (19) 6 (21)
Rhinorrhoea 10 (14) 45 (12) 11 (16) 5 (18)
Nausea 21 (28) 19 (5) 18 (26) 9 (31)
Haemorrhagic manifestations 0 0 19 (5) 1 (1.4) 1 (3.2)
Conjunctivitis 0 0 0 1 (1.4) 1 (3.2)
Diarrhoea 0 1 (100) 4 (1.2) 1 (1.4) 2 (6.4)
Encephalitis 0 0 0 1 (1.4) 1 (3.2)
Figure 2

Yearwise distribution of cases

https://s3-us-west-2.amazonaws.com/typeset-media-server/6be6b598-ce49-493c-bcca-1b6f3c861700image2.png
Figure 3

Seasonal variation in circulation of H1N1

https://s3-us-west-2.amazonaws.com/typeset-media-server/6be6b598-ce49-493c-bcca-1b6f3c861700image3.png

Discussion

India witnessed one of the large Influenza A (H1N1) pandemic 09 outbreak in 2009 and had 27,236 confirmed cases and 981 deaths. During post pandemic period in 2010, 20,604 confirmed cases with more deaths (1763) were reported. Severely affected states were Maharashtra, Delhi , Rajasthan, Gujarat , Madhya Pradesh, Karnataka , Haryana, Kerala, Tamil Nadu and Andhra Pradesh with high fatality in Rajasthan. Another influenza outbreak hit in India in 2015, during which most affected states were Rajasthan, Gujarat , Delhi Maharashtra, Karnataka and Madhya Pradesh with more number of deaths in Rajasthan and Gujarat.8 Integrated Disease Surveillance Programme (IDSP) data show that the epidemiology of influenza A (H1N1) is changing in terms of geographical distribution, age and seasonality but studies related to this are scarce. In our study, we tried to focus on changing trends of influenza activity in central India. Influenza activity continue to be reported every year, more during winter. However, as per IDSP data, 2017 was an unusual year, with the virus spreading rapidly throughout the country, and showing different epidemiological parameters as compared to previous years in terms of period (two peaks observed), place (infection reported for the first time from some of the north-eastern states) and person (comparatively more cases among children).9 In our study , we found maximum suspected and positive cases in the year 2017 in last five years in spite of year 2017 being hotter than normal in last 15 years. Our study showed and support similar change in time periods of peaks of circulation of H1N1 in 2017, 2018 and 2019 where we got two peaks, one in Mar-May and other during Aug-Nov. Similar findings of two peaks in a year is also seen in an outbreak reported by Mudhigeti N et al. in Andra Pradesh.10 But some studies showed winter prevalence of H1N111, 12 and some showed post monsoon peaks.13, 14 In one more study by Broor et al., maximum cases were reported in rainy season. 15 Dual peaks have also been reported from other Indian author’s 16 and other parts of the globe.17, 18

Althrough these years, age group 21-40 and 41-60 years were mostly affected in our study. Since 2017, we noted shift in age group towards 0-10 and 11-20 years. In 2018 and 2019, again younger age groups found to be mostly affected in our study. In a study by Ganesh Nandhini et al., maximum positivity was seen in age group 20-49 years19 and in 51-60 years by Prasad S et al.20 While Siddharth et al.12 stated that influenza A H1N1 pandemic 09 relatively spared the older population and had stricken the younger population. The age shift in our study shows that virus has now started establishing in all age groups more towards younger population. This needs high alert suspicion of the infection and demands increased attention. Majority of the positive cases had the clinical manifestations of fever, breathlessness, cough, followed by sore throat and myalgia. Apart from respiratory symptoms, cases also presented with diarrhea, nausea, haemmorhagic manifestations and conjunctivitis. In a study, the main presenting symptom was fever that is 83.3%, followed by dyspnea (76.7%), cough (70%), throat pain and least common was chest pain. 21 While KN Bhatt et al. reported , nausea/ vomitting along with respiratory symptoms similar to our study.16 Many other studies have reported similar clinical findings with changing percentage.22, 23 In our study, female patients were more with Influenza like illness (ILI) than male patients; But no significant difference in positivity among males and females was noted. Similar findings are also given by KN Bhatt et al. and Mudhigeti N et al and Amaravathi KS et al.24 In a study by Arvind Chandora et al. where they compared six year’s data from 2011-2015 as in our study and25 they found that female population was more (>50%) than male from 2010 to 2014 but in year 2015 male population was more (>50%) than female. But in our study, in current year 2019, females are more affected (12%) than males (7%) which is statistically significant. Different set of years of study period could be a reason for this opposite findings. Similar to our study, Prasad S et al. also showed slight female preponderance. As pregnancy is a known risk factor among females to acquire more complications due to H1N1,26 slight shift of infection towards females demands keen vigilance and rapid management. The geographic region is also widened by the virus due to increased travel. Almost all districts of Vidarbha region are having peaks of infection in one or the other year. More population is now at high risk of getting infection by H1N1 making it a big public health challenger. Though percent positivity is decreasing down these years, changing epidemiology of the virus needs attention. Based on molecular analysis of isolates from Chennai and Pune, the dominant flu strain in India during 2017 was A/ Michigan/7/2009 (H1N1) pandemic 09 virus, replacing A/California/7/ 2009 (H1N1) pandemic 09 seen during 2016.27 This is not an antigenic shift but a minor drift, but this change in circulating strain should be a focus of future research. WHO listed the virus in ‘Top Ten Threat’s’ world can face in 2019. Who says- ‘The world will face another influenza pandemic  – the only thing we don’t know is when it will hit and how severe it will be. Global defences are only as effective as the weakest link in any country’s health emergency preparedness and response system.’28

Conclusion

Although the pandemic era of H1N1 has settled, epidemics are a constant reminder of the hidden danger. Silent spread of the virus has to be kept an eye on to see - What is changing/ changed/ expected to change ?

  1. Epidemiology

  2. Agent

  3. Clinical Features

  4. Diagnostics

  5. Treatment

  6. Prevention

Acknowledgment

We are thankful to DHR-ICMR, New Delhi for their financial support and to NIV, Pune for their constant support and guidance. Thanks are also due to Asmita Babhulkar and Harish Nimbhorkar for their technical support.

Source of funding

None.

Conflict of interest

None.

References

1 

Influenza (Seasonal), World Health Organization2009http://www.who.int/mediacentre/factsheets/fs211/en/

2 

World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director General - Dr Margaret Chanhttp://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html

3 

Ministry of Health and Family Welfare, India. Information on Swine Flu. New Delhi: MOHFWhttp:// www.mohfw.nic.in/swineflu.htm

4 

World Health Organization. H1N1 in post pandemic periodhttp://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html

6 

SanketVasant Kulkarni JaiP Narain Sunil Gupta AkshayC Dhariwal SujeetKumar Singh CRaina Macintyre Influenza A (H1N1) in India: Changing epidemiology and its implicationsNational Med J India2019

7 

7.Ministry of Health and Family Welfare. Guidelines on Categorization of Influenza A H1N1 Cases During Screening for Home Isolation, Testing Treatment, and Hospitalization. India: Ministry of Health and Family Welfare2016http://www.mohfw.nic.in/showfile.php?lid=3071

8 

Seasonal Influenza (H1N1) - State/ UT- wise, Year- Wise Number of Cases and Death from2010Availableatwww.idsp.nic.in/showfile.php?lid=3908

9 

SanketVasant Kulkarni JaiP Narain Sunil Gupta AkshayC Dhariwal SujeetKumar Singh CRaina Macintyre Influenza A (H1N1) in India: Changing epidemiology and its implications National Med J India2019

10 

Usha Kalawat Nagaraja Mudhigeti RishiGowtham Racherla PadmalathaAnjaneyulu Mahalakshmi MadhaviLatha Pamireddy Umapathi Nallapireddy A study of influenza 2017–2018 outbreak in Andhra Pradesh, IndiaIndian J Med Microbiol201836526526

11 

R K Chudasama U V Patel P B Verma C D Amin D Savaria R Ninama Clinico-epidemiological features of the hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in Saurashtra region128India200911

12 

Vijaydeep Siddharth Vineet Goyal VipinKumar Koushal Clinical-Epidemiological Profile of Influenza A H1N1 Cases at a Tertiary Care Institute of IndiaIndian J Comm Med201237232

13 

Y K Gurav S D Pawar M S Chadha V A Potdar A S Deshpande S S Koratkar Pandemic influenza A (H1N1) 2009 outbreak in a residential school at Panchgani, Maharashtra, IndiaIndian J Med Res201013246771

14 

D K Biswas P Kaur M Murhekar R Bhunia An outbreak of pandemic influenza A (H1N1) in Kolkata135West Bengal, India2010529529

15 

Shobha Broor Anand Krishnan Dipanjan S. Roy Shivram Dhakad Samander Kaushik Muneer A. Mir Dynamic Patterns of Circulating Seasonal and Pandemic A(H1N1)pdm09 Influenza Viruses From 2007–2010 in and around Delhi, IndiaPLoS ONE201271e29129e29129

16 

K N Bhatt S C Jethw D Bhadiyadar D Patel K Joshi Study of clinical profile in patients with H1N1 influenza in Surat districtJ Assoc Physicians India2009601524

17 

H L Nguyen R Saito H K Ngiem M Nishikawa Y Shobugawa D C Nguyen Epidemiology of influenza in HanoiJ Infect20015515863

18 

A. J Elliot C. Powers A. Thornton C. Obi C. Hill I. Simms Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS DirectBMJ2009339b3403b3403

19 

Ganesh Nandhini Sistla Sujatha Epidemiology of influenza viruses from 2009 to 2013 – A sentinel surveillance report from Union territory of Puducherry, IndiaAsian Pacific J Trop Med20158718723

20 

Sethulakshmi Prasad AJ Indhu RAthish Peter Margos Shoba Philip Clinical profile and outcome of H1N1 influenza patients in a tertiary care hospital in Kochi, KeralaIndian J Respir Care20187297

21 

Varuna Jethani Rakhee Khanduri Sushant Khanduri Neha Taneja Ankit Aggarwal Retrospective study of clinical profile and management of patients with swine flu at tertiary care hospitalInt J Res Med Sci201871251254

22 

Parvaiz Koul Varsha Potdar Hyder Mir Mandeep Chadha The 2015 Outbreak of Severe Influenza in Kashmir, North India: Emergence of a New Clade of A/H1n1 Influenza VirusPLoS Curr201810

23 

NV Khara RM Kshatriya Jaishree Ganjiwale SD Lote SN Patel RP Paliwal Lessons learnt from the Indian H1N1 (swine flu) epidemic: Predictors of outcome based on epidemiological and clinical profileJ Family Med Primary Care2018715062249-4863Medknowhttps://dx.doi.org/10.4103/jfmpc.jfmpc_38_18

24 

KadadanamariSubbaramareddy Amaravathi Putrevu Sakuntala Budithi Sudarsi Siddula Manohar Ramapantula Nagamani SunkaraRajeswar Rao Clinical profile and outcome of recent outbreak of influenza A H1N1 (swine flu) at a tertiary care center in Hyderabad, TelanganaAnn Tropi Med Public Health201586267

25 

Arvind Chandora P K Khatri Saroj Meena Archana Bora Laxmi Rathore Niranjan Sharma Study of Swine Flu Virus Re-Emergence in Western Rajasthan Jodhpur in Reference to Different Age Groups (Risk Factor)Int J Curr Microbiol Appl Sci20154352358

26 

Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. InClinical management of human infection with pandemic (H1N1) 2009: revised guidance2009

28 

World Health Organization. Ten threats to global health in 20192019



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File  


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmmtd.2020.007


Article Metrics






Article Access statistics

Viewed: 1299

PDF Downloaded: 555



Medical Abbreviation List